Literature DB >> 2441930

Public epitopes and the antigenic structure of the HLA molecules.

G E Rodey, T C Fuller.   

Abstract

Simplified procedures for determining amino acid sequences in proteins and nucleotide sequences in DNA have rapidly expanded the number of MHC molecules for which primary amino acid structure is known. These molecules will be especially valuable as tools to study the structure-function relationships of globular proteins because of the extensive polymorphism of genes coding the MHC genes products. The general three-dimensional structure of class I MHC molecules was recently deduced, but the more subtle topographical microconformations are still undefined. Definition and topographical mapping of epitopes, defined by serological or cellular immune effector products, will be critical probes for these three-dimensional studies. Comparative studies of amino acid sequences among various MHC and molecules have revealed distinct regions of hypervariability in the alpha-1 and -2 domains of class I heavy chains and the alpha-1 and beta-1 domains of most class II molecules. Mutant MHC molecules that differ from each other by no more than one to three amino acids can have structural changes which may result in a loss of the private epitopes that defined the allelic gene product. On the basis of these studies, the private epitopes are thought to be determined by one or more of the hypervariable regions. Similar studies of the relationships between specific regions of the molecule and public epitopes are not fully explored. Because public epitopes are partially conserved structures, one might expect that their structure is not principally determined by hypervariable region. In fact, however, some public epitopes, such as A2/B17 and BW4/Bw6, do map to diversity regions. Epitope mapping as a means of identifying specific topographic sites and relating these sites to specific functional regions of the molecule will be difficult unless the epitopes themselves are better defined. Thus, the capacity to distinguish spatially distinct public epitopes from cross-reactive homologous private epitopes will be important if epitope-specific immunological probes are use to map specific regions of an MHC molecule. Many investigators are interested in the possibility that some components of HLA alloimmunization are regulated through idiotypic networks. Suciu-Foca and colleagues have provided preliminary evidence that epitope-specific HLA alloantibodies bear dominant idiotypic determinants. Antibodies to these determinants appear during pregnancy, following blood tranfusion, and following renal allograft transplantation, also, the antibodies have been correlated with renal allograft survival.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441930

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  14 in total

Review 1.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.

Authors:  Judith A Wade; Carolyn Katovich Hurley; Steven K Takemoto; John Thompson; Stella M Davies; Thomas C Fuller; Glenn Rodey; Dennis L Confer; Harriet Noreen; Michael Haagenson; Fangyu Kan; John Klein; Mary Eapen; Stephen Spellman; Craig Kollman
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

3.  Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation.

Authors:  R J Duquesnoy; L T White; J W Fierst; M Vanek; B F Banner; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

4.  Simplification of complex DNA profiles using front end cell separation and probabilistic modeling.

Authors:  Nancy A Stokes; Cristina E Stanciu; Emily R Brocato; Christopher J Ehrhardt; Susan A Greenspoon
Journal:  Forensic Sci Int Genet       Date:  2018-07-17       Impact factor: 4.882

5.  HLA and cross-reactive antigen group matching for cadaver kidney allocation.

Authors:  T E Starzl; M Eliasziw; D Gjertson; P I Terasaki; J J Fung; M Trucco; J Martell; J McMichael; V Scantlebury; R Shapiro; A Donner
Journal:  Transplantation       Date:  1997-10-15       Impact factor: 4.939

Review 6.  Evolution of HLA antibody detection: technology emulating biology.

Authors:  Robert A Bray; Peter W Nickerson; Ronald H Kerman; Howard M Gebel
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  A glow of HLA typing in organ transplantation.

Authors:  Batool Mutar Mahdi
Journal:  Clin Transl Med       Date:  2013-02-23

8.  Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in Brazil.

Authors:  Carolina Bonet Bub; Margareth Afonso Torres; Maria Elisa Moraes; Nelson Hamerschlak; José Mauro Kutner
Journal:  Rev Bras Hematol Hemoter       Date:  2015-11-28

9.  The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors.

Authors:  Anna Koclega; Miroslaw Markiewicz; Urszula Siekiera; Alicja Dobrowolska; Mizia Sylwia; Monika Dzierzak-Mietla; Patrycja Zielinska; Malgorzata Sobczyk Kruszelnicka; Andrzej Lange; Slawomira Kyrcz-Krzemien
Journal:  Bone Marrow Res       Date:  2012-10-24

10.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

Authors:  J E Gumperz; V Litwin; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.